Pages that link to "Q33994334"
Jump to navigation
Jump to search
The following pages link to Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. (Q33994334):
Displaying 48 items.
- Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder Cancer (Q26765951) (← links)
- Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-Analysis (Q26786160) (← links)
- Neutrophil to Lymphocyte Ratio (NLR) at the Time of Transurethral Resection of Bladder Tumor: A Large Retrospective Study and Analysis of Racial Differences (Q33614530) (← links)
- Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis (Q34226276) (← links)
- The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experience (Q35586693) (← links)
- The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy (Q35677849) (← links)
- Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma (Q35813764) (← links)
- Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer (Q35925423) (← links)
- Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer (Q36069609) (← links)
- Prognostic value of CD66b positive tumor-infiltrating neutrophils in testicular germ cell tumor (Q36198184) (← links)
- Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma (Q36287097) (← links)
- Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy (Q36654421) (← links)
- Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy (Q36750736) (← links)
- Tailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of Bladder (Q37068034) (← links)
- Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study (Q37221777) (← links)
- The Prognostic Value of Serum Biomarkers in Localized Bone Sarcoma (Q37221912) (← links)
- Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy (Q37378328) (← links)
- Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer (Q37442989) (← links)
- Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor (Q37706516) (← links)
- The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis (Q38656066) (← links)
- Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy. (Q38833996) (← links)
- Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy. (Q39010863) (← links)
- A simple prognostic model involving prostate-specific antigen, alkaline phosphatase and albumin for predicting the time required to progress to castration-resistant prostate cancer in patients who received androgen deprivation therapy (Q39193374) (← links)
- Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710. (Q39243899) (← links)
- Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy (Q39869134) (← links)
- Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy (Q41691026) (← links)
- Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis (Q42365361) (← links)
- Inflammatory microenvironment in the initiation and progression of bladder cancer (Q46779353) (← links)
- The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. (Q47338550) (← links)
- Pre-treatment neutrophil-to-lymphocyte ratio predicts survival in patients with laryngeal cancer (Q49334897) (← links)
- The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients (Q51031663) (← links)
- Baseline neutrophil-to-lymphocyte ratio predicts the prognosis of castration-resistant prostate cancer treated with abiraterone acetate (Q51740033) (← links)
- Evaluation of the clinical value of hematological parameters in patients with urothelial carcinoma of the bladder. (Q52604939) (← links)
- Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. (Q52683143) (← links)
- Pretreatment neutrophil-to-lymphocyte ratio predicts worse survival outcomes and advanced tumor staging in patients undergoing radical cystectomy for bladder cancer. (Q52701379) (← links)
- High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer. (Q52822215) (← links)
- Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. (Q53185271) (← links)
- Editorial Comment to Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study. (Q53533473) (← links)
- The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study. (Q54964281) (← links)
- Predictive role of neutrophil-to-lymphocyte ratio on upstaging of organ-confined invasive urothelial bladder cancer to non-organ-confined disease. (Q55175395) (← links)
- Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting (Q61814315) (← links)
- Understanding the predictive value of continuous markers for censored survival data using a likelihood ratio approach (Q64279170) (← links)
- The prognostic role of preoperative circulating neutrophil-lymphocyte ratio in primary bladder cancer patients undergoing radical cystectomy: a meta-analysis (Q90235552) (← links)
- Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108 (Q90458910) (← links)
- Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer (Q90498824) (← links)
- Prognostic significance of serum γ-glutamyltransferase in patients with advanced urothelial carcinoma (Q93379759) (← links)
- Prognostic significance of serum lactate dehydrogenase in patients undergoing radical cystectomy for bladder cancer (Q97093355) (← links)
- Role of Systemic Inflammatory Response Markers in Urothelial Carcinoma (Q99712017) (← links)